RMD · ResMed Inc.

Healthcare NYQ United States resmed.com ↗
Val Gro Qua Mom Sta Cap P/S5.57 P/E Fwd P/E16.50 PEG1.28 52W –  RSI Target$246.44 (+12.9%) Beta0.77 Div1.09%
Loading chart…
RSI ()
Pattern Overlays
Loading patterns…
Medical Instruments & Supplies San Diego, United States 11,370 employees
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 42 Overbought · 100
Signal Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
8Bullish
4Bearish
0Neutral

Key Signals 2

▲ Double Bottom Major reversal 2026-06-26 · $199.42
Two lows ~$181.94 — bullish reversal confirmed
Learn more →
▲ Double Bottom Major reversal 2026-08-04 · $221.79
Two lows ~$186.92 — bullish reversal confirmed
Learn more →

Momentum Signals 10

▲ MACD Bullish Crossover 2026-05-18 · $203.57
▲ MACD Bullish Crossover 2026-06-09 · $196.38
▲ Bull Flag 2026-07-02 · $202.64
▲ MACD Bullish Crossover 2026-07-28 · $208.36

View overlays on the price chart via Overview tab → Pattern Overlays.

Next Earnings Oct 29, 2026
Beat Rate 100%
Consensus BUY
Analyst Upside +12.9%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
100% 8/8 quarters
Wall Street Consensus
BUY
7
11
1
BuyHoldSell
Price Target Range
$246.44 +12.9% upside
Low $175 High $320
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 61.62%Last 12 Months
Operating Margin 30.86%Last 12 Months
Return on Equity 24.27%Last 12 Months
Revenue Growth 8.60%Year over Year
Free Cash Flow 939.25MLast 12 Months
Free Cash Flow Yield Last 12 Months
Balance Sheet
Debt / Equity 12.54Most Recent Quarter
Current Ratio 3.10Most Recent Quarter
Cash 1.47BMost Recent Quarter
Total Debt 825.92MMost Recent Quarter
Net Debt Most Recent Quarter
How RMD Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap31.49B
Enterprise Value30.84B
Trailing P/E21.05
Forward P/E16.50
PEG Ratio (5yr)1.28
Price/Sales (ttm)5.57
Price/Book (mrq)4.78
EV/Revenue5.46
EV/EBITDA14.72
Share Statistics
Avg Vol (3m)1.50M
Shares Outstanding144.25M
Float143.36M
% Held by Insiders0.50%
% Held by Institutions71.27%
Short Ratio8.34
Short % of Float10.45%
Profitability
Gross Margin61.62%
Operating Margin (ttm)30.86%
Profit Margin26.95%
Return on Assets (ttm)14.00%
Return on Equity (ttm)24.27%
Income Statement
Revenue (ttm)5.65B
Revenue Growth (yoy)8.60%
Gross Profit (ttm)3.48B
EBITDA2.10B
Net Income (ttm)1.52B
Diluted EPS (ttm)10.37
EPS Growth (yoy)2.40%
Balance Sheet
Total Cash (mrq)1.47B
Total Debt (mrq)825.92M
Debt / Equity (mrq)12.54
Current Ratio (mrq)3.10
Book Value / Share45.66
Operating CF (ttm)1.81B
Free Cash Flow (ttm)939.25M
Trading & Dividends
Beta (5Y)0.77
50-Day MA216.62
200-Day MA228.02
Fwd Dividend Yield1.20%
Payout Ratio23.01%
Income
Dividend Yield 1.09%Last 12 Months
Annual Rate 2.64Forward
Payout Ratio 23.01%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 23.01%
Monthly Dividends
Ownership Breakdown
Institutional 71.27% Insider 0.50% Public 28.2%
Short Interest 10.45% of float
High
Institutional 13F Holdings

Famous investors who disclosed a position in RMD in their latest SEC 13F filing.

Loading…
Insider Transactions
Date Insider Role Transaction Shares Price Value